Cognizant的合作伙伴关系 - Cognizant与NVIDIA和Microsoft合作，利用gen AI技术改变药物发现和医疗管理领域[1][2] - Cognizant与Microsoft合作将gen AI整合到医疗管理中，旨在提高效率和患者护理质量[5][6] - Cognizant的强大合作伙伴基础包括Microsoft、NVIDIA和ServiceNow，推动公司前景[7][10] - Cognizant与ServiceNow合作，增强WorkNEXT现代工作场所服务解决方案[9] - Cognizant与CNO Financial合作，优化技术服务和解决方案[10][11] gen AI技术的应用 - gen AI技术有望简化药物开发流程，提高生产力，加速治疗方案上市[4] - Cognizant推出了基于gen AI技术的创新助手，加强内部创新倡议[8] - Cognizant推出了Flowsource平台，采用gen AI技术，革新企业软件工程领域[12] 财务展望 - Cognizant预计2024年第一季度营收将下降，但市场预期仍保持稳定[13][14]

Cognizant's AI and industry expertise, combined with the NVIDIA BioNeMo generative AI platform, create a strong foundation to improve outcomes in the healthcare and life sciences sectors TEANECK, N.J., March 19, 2024 /PRNewswire/ -- Cognizant (NASDAQ: CTSH) is advancing the application of generative AI (gen AI) technology with the NVIDIA BioNeMo platform to solve complex challenges of drug discovery in the life sciences industry, such as improving productivity in the development process and increasing the s ...

Cognizant Technology Solutions (CTSH) entered into a recent partnership with Microsoft (MSFT) within the healthcare sector, aimed at transforming healthcare administration. The partnership focuses on integrating generative AI into the TriZetto Assistant on Facets, a crucial component of Cognizant's TriZetto software platform powered by Microsoft Azure. The initiative aims to elevate productivity and efficiency for healthcare payers and providers, with a primary focus on ensuring timely responses and enhanci ...

财务表现 - Cognizant第四季度2023年非GAAP每股收益为1.18美元，超出Zacks Consensus Estimate 13.46%，同比增长16.8%[3] - 第四季度营收为47.6亿美元，低于预期，同比下降1.7%[4] - 在过去12个月中，订单额同比增长9%，达到263亿美元，约为1.4倍的订单额[6] - 金融服务收入同比下降5.8%，健康科学收入同比下降2.1%，产品和资源收入同比增长1.9%，通信、媒体和技术收入同比增长2.6%[7][8][9][10] - 北美地区收入同比下降1.6%，欧洲收入同比增长1.3%，英国收入同比下降1.1%，大陆欧洲收入增长3.8%[11][12][13] - 第四季度末总员工数为347,700人，同比减少7,600人，环比增加1,100人[15] 未来展望 - 2024年第一季度预计营收在46.8亿至47.6亿美元之间，同比下降2.7%至1.2%[22] - 2024年预计调整后的运营利润率在15.3%至15.5%之间，调整后的盈利预计在4.50至4.68美元每股之间[25] - Cognizant计划通过股票回购和定期季度股息向股东返还10亿美元[27]

The launch of Cognizant's Advanced AI Lab comes at a time when enterprises are rapidly working to understand the impact of AI and meet expanding expectations around its promise. Recent research has shown more than half (66 percent) of executives are ambivalent or dissatisfied with their company's progress on AI and gen AI, and most executives (85 percent) plan to increase spending on AI and gen AI in 2024. Longer term, Cognizant and Oxford Economics' recent study found gen AI could inject up to $1 trillion ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-24429 COGNIZANT TECHNOLOGY SOLUTIONS CORPORATION (Exact Name of Registrant as Specified in Its Charter) Delaware 13-3728359 (State or O ...

Cognizant Technology Solutions (CTSH) reported fourth-quarter 2023 non-GAAP earnings of $1.18 per share, which beat the Zacks Consensus Estimate by 13.46% and increased 16.8% year over year. Revenues of $4.76 billion lagged the consensus mark by 0.08%. The top line decreased 1.7% year over year and 2.4% at constant currency (cc). Acquisitions contributed 90 basis points (bps) to top-line growth. Cognizant’s fourth-quarter results suffered from a challenging macroeconomic environment, cautious clients and li ...

财务表现 - Cognizant (CTSH)在2023年12月结束的季度报告显示，营收为47.6亿美元，同比下降1.7%[1] - 公司的每股收益为1.18美元，较去年同期的1.01美元有所增长[1] - Cognizant的营收与Zacks Consensus Estimate的47.6亿美元相比，出现-0.08%的惊喜[2] - 公司的每股收益惊喜达到+13.46%，而共识每股收益预期为1.04美元[2] 业绩指标 - 在场利用率为88%，与两位分析师平均估计的88.8%相比[5] - 总人数为347,700人，而两位分析师平均估计为346,093人[5] - 离岸利用率为79%，与两位分析师平均估计的79%相同[5] 地区营收 - 北美地区营收为35.3亿美元，与两位分析师平均估计的35.4亿美元相比，同比下降1.6%[6] - 英国地区营收为4.48亿美元，与两位分析师平均估计的4.7152亿美元相比，同比下降1.1%[7] - 其他地区营收为3.1亿美元，与两位分析师平均估计的2.9426亿美元相比，同比下降9.9%[8] - 欧洲地区营收为9.18亿美元，与两位分析师平均估计的9.308亿美元相比，同比增长1.3%[8] - 大陆欧洲地区营收为4.7亿美元，与两位分析师平均估计的4.5928亿美元相比，同比增长3.8%[9] 行业营收 - 产品和资源营收为11.6亿美元，与三位分析师平均估计的11.6亿美元相比，同比增长1.3%[10] - 医疗科学营收为14亿美元，与三位分析师平均估计的14.4亿美元相比，同比下降2.1%[11] - 金融服务营收为14亿美元，与三位分析师平均估计的14.5亿美元相比，同比下降5.8%[11] - 通讯、媒体和技术营收为8.04亿美元，与三位分析师平均估计的7.1988亿美元相比，同比增长2.6%[12] 股票表现 - Cognizant的股票在过去一个月内上涨了5.3%，表现优于Zacks S&P 500综合指数的5.3%变化[13]

Cognizant (CTSH) came out with quarterly earnings of $1.18 per share, beating the Zacks Consensus Estimate of $1.04 per share. This compares to earnings of $1.01 per share a year ago. These figures are adjusted for non- recurring items. This quarterly report represents an earnings surprise of 13.46%. A quarter ago, it was expected that this information technology consulting and outsourcing firm would post earnings of $1.08 per share when it actually produced earnings of $1.16, delivering a surprise of 7.41% ...

Cognizant Technology Solutions (CTSH) is scheduled to report its fourth-quarter 2023 results on Feb 6. CTSH expects fourth-quarter 2023 revenues to be between $4.69 billion and $4.82 billion, indicating a decline of 3.1% to an increase of 0.3%. Acquisitions are expected to contribute 100 basis points (bps). The Zacks Consensus Estimate for the fourth quarter is pegged at $4.76 billion, indicating a year-over-year decline of 1.6%. The consensus mark for earnings is pegged at $1.04 per share, unchanged in the ...